Log In
BCIQ
Print this Print this
 

Impact Dx Factor V Leiden and Factor II Genotyping Test

  Manage Alerts
Collapse Summary General Information
Company Laboratory Corp. of America Holdings
DescriptionGenotyping test that aids in the diagnosis of thrombophilia
Molecular Target Factor V (FVL)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationHematology, Diagnostic
Indication DetailsAid in the diagnosis of thrombophilia
Regulatory Designation
PartnerAgena Bioscience Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$302.0M

$302.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/07/2016

$302.0M

$302.0M

0

Get a free BioCentury trial today